Yes—for many people, early fatty liver disease gets better with sustained weight loss and a change in eating pattern, especially when it’s caught before scarring sets in. The clearest evidence points to Mediterranean-style eating, modest and steady weight loss rather than crash dieting, less added sugar and fructose, and limited alcohol. More advanced disease, with inflammation or scarring, also responds to these changes, though it usually takes more weight loss, more time, and sometimes a medication alongside diet3. This article explains what the diagnosis means and what the evidence supports. It is general information, not a substitute for guidance from your own doctor or dietitian.
What MASLD and MASH Are, and Why the Names Changed
In June 2023, a multisociety panel representing hepatology associations in the Americas, Europe, and Latin America replaced “nonalcoholic fatty liver disease” (NAFLD) with metabolic dysfunction-associated steatotic liver disease (MASLD). The more advanced, inflamed form once called NASH is now metabolic dysfunction-associated steatohepatitis (MASH)1. The change was not cosmetic. The old names were defined by exclusion—fatty liver not caused by alcohol—and “nonalcoholic” struck many patients and clinicians as stigmatizing. The new definition is positive: MASLD is diagnosed when there is fat in the liver, seen on imaging or biopsy, plus at least one of five cardiometabolic risk factors, such as a higher body mass index or waist size, elevated blood pressure, high triglycerides, low HDL cholesterol, or prediabetes or type 2 diabetes1. A related category, MetALD, describes people who meet the metabolic criteria but also drink more alcohol than the MASLD definition allows1.
Practically, MASLD is a liver condition rooted in the same metabolic issues that drive type 2 diabetes and heart disease—insulin resistance, excess visceral fat, and a diet pattern that keeps blood sugar and triglycerides running high, which is why treatment looks like treatment for those conditions: food, activity, and weight management, with medication reserved for more advanced cases2. NIDDK estimates that roughly 24% of U.S. adults have NAFLD/MASLD, with the more serious NASH/MASH form affecting an estimated 1.5% to 6.5% of adults, and notes that close to 10% of U.S. children ages 2 to 19 have the condition4. Most people with simple fatty liver never develop symptoms and find out incidentally, from an ultrasound or blood test done for another reason.
How Much Weight Loss Matters, and Why Crash Diets Aren’t the Answer
The American Association for the Study of Liver Diseases (AASLD) 2023 Practice Guidance is specific about how much weight loss changes the liver. Losing about 3% to 5% of body weight tends to reduce the fat itself (steatosis). Reducing inflammation and early scarring (fibrosis) takes more: the guidance describes weight loss greater than 7% to 10% as typically needed to improve steatohepatitis and fibrosis3. That is a meaningful amount for most people, and it explains why fatty liver treatment is measured in months, not weeks.
It also explains why fast, restrictive diets tend to backfire. Rapid weight loss can worsen liver inflammation in the short term, and weight regained quickly after a crash diet often returns preferentially as visceral and liver fat. A more realistic target is roughly 0.5 to 1 kilogram (about 1 to 2 pounds) per week, built on a moderate calorie deficit you can sustain for a year, not eight weeks. Our guide to sustainable weight management covers how to build that pace into a realistic plan. Because MASLD tracks closely with insulin resistance, many people also benefit from the eating pattern used to manage blood sugar and type 2 diabetes.
The Eating Pattern With the Best Evidence: Mediterranean-Style
Of all the diets studied for fatty liver, the Mediterranean pattern has the strongest evidence, and it is the pattern AASLD’s guidance highlights by name, both for reducing liver fat and for cardiovascular benefit—important, since cardiovascular disease is the leading cause of death in people with MASLD3. It is not a rigid meal plan but a pattern built around vegetables, fruit, legumes, whole grains, nuts, and extra-virgin olive oil, with fish more often than red meat, and it naturally limits the refined carbohydrates and added sugars that drive liver fat. The table below is a starting point, not a strict rulebook.
| Emphasize | Limit | Avoid or minimize |
|---|---|---|
| Non-starchy vegetables, at most meals | Red meat, a few times a month | Sugar-sweetened sodas, juices, and sweet tea |
| Whole fruit, not juice | Refined white bread, pastries, and white rice | Deep-fried foods |
| Beans, lentils, and other legumes | Butter and full-fat dairy, moderate portions | Ultra-processed snacks high in added sugar |
| Whole grains: oats, quinoa, farro | Alcohol, within your clinician’s guidance | High-fructose corn syrup as a top ingredient |
| Extra-virgin olive oil as the main fat | Salty, packaged convenience meals | “Liver detox” teas and unproven cleanses |
| Fish and seafood, a couple of times weekly | Processed and cured meats | Trans fats (partially hydrogenated oils) |
Sugar, Fructose, and Drinks
If one change moves the needle fastest, it is cutting added sugar, and fructose specifically. AASLD’s guidance notes that excessive fructose intake raises the risk of fatty liver, steatohepatitis, and advanced fibrosis independent of total calorie intake, and advises against diets heavy in refined carbohydrates and sugar-sweetened beverages3. NIDDK’s patient guidance recommends avoiding foods and drinks with large amounts of simple sugars, especially fructose, including the high-fructose corn syrup common in soda and fruit juice5. In practice, treat regular soda, sweetened iced tea, and most bottled juices as occasional choices, and check labels for corn syrup or cane sugar near the top of the ingredient list.
Alcohol and Your Liver
Alcohol guidance for MASLD is more nuanced than a flat “never.” AASLD’s guidance notes that heavy drinking clearly accelerates liver injury and fibrosis and should be avoided, and that even moderate intake appears to raise the probability of advanced fibrosis, particularly with obesity or type 2 diabetes; it describes the benefit of light drinking as unclear3. NIDDK’s advice to patients is simpler: if you have NAFLD, minimize alcohol use, since it can further damage the liver5. If you already have MASH, bridging fibrosis, or cirrhosis, most hepatologists recommend avoiding alcohol entirely. The safest approach is to treat regular drinking as something to reduce, and heavy or binge drinking as something to stop, in discussion with your own doctor.
Coffee: A Small, Consistent Upside
Coffee is one of the few things in this diet with good news attached. AASLD’s guidance states that drinking three or more cups a day is associated with lower risk of NAFLD and slower fibrosis progression, and that this level of intake could reasonably be recommended in people without a medical reason to avoid caffeine3. It is not a treatment on its own and does not offset a poor diet, but for most adults it is a low-risk habit worth keeping. The benefit applies to brewed coffee, not the sugar and cream added to it.
Protein and Muscle Mass During Weight Loss
Losing weight without losing muscle matters in fatty liver, because muscle stores a large share of dietary glucose, and lower muscle mass is linked to worse insulin resistance. During a calorie deficit, spreading protein across meals—lean meat, poultry, fish, eggs, dairy, tofu, and legumes—combined with resistance exercise helps preserve muscle while liver fat comes down. A Mediterranean-style pattern supports this well: fish, legumes, and yogurt provide protein without relying on the processed and cured meats AASLD’s guidance advises limiting3. A dietitian can set a protein target that fits your weight, kidney function, and activity level, since needs vary by individual.
A Sample Day of Eating
There is no single required meal plan for MASLD; the overall pattern held consistently matters most. The example below shows a Mediterranean-style day, described by portion rather than exact amounts, since calorie and protein needs vary.
| Meal | Example |
|---|---|
| Breakfast | Plain yogurt with berries and a small handful of walnuts, unsweetened coffee |
| Lunch | Large salad with chickpeas, vegetables, olive oil and lemon dressing, small portion of whole-grain bread |
| Snack | Apple slices with a small portion of unsalted nuts |
| Dinner | Baked salmon or lentil stew, a generous portion of roasted vegetables, small portion of quinoa or farro |
| Evening | Herbal tea or sparkling water instead of a sweetened dessert or a second alcoholic drink |
Exercise: Diet’s Partner, Not a Substitute
Diet change and physical activity work together, and neither fully replaces the other. AASLD’s guidance recommends regular moderate exercise, at least 150 minutes per week, to help prevent and improve fatty liver, noting that more vigorous exercise appears necessary to improve liver histology—the tissue changes seen on biopsy—rather than fat content alone3. A mix of activity that raises your heart rate most days, plus two sessions of resistance training to protect muscle during weight loss, is a reasonable target for most adults with MASLD. You do not need to wait until your diet is perfect to start moving more.
Medications for MASH, and Where Diet Still Fits
Diet remains the foundation of MASLD care, but for people with MASH and moderate to advanced fibrosis, medication options now exist alongside diet. In March 2024, the FDA approved resmetirom (Rezdiffra) as the first medication for adults with noncirrhotic MASH and moderate to advanced liver fibrosis, to be used together with diet and exercise, not in place of them7. In August 2025, the FDA approved a new indication for semaglutide (Wegovy) for noncirrhotic MASH with moderate to advanced fibrosis, based on trial results showing improved liver inflammation and fibrosis—the first GLP-1 medicine approved for this use8. If you already take a GLP-1 medication, our article on GLP-1 medications and medical nutrition therapy covers how nutrition needs shift alongside these drugs, including protecting muscle mass.
Vitamin E (800 IU daily) is sometimes recommended for adults with biopsy-proven MASH who do not have diabetes or cirrhosis, since it can improve liver histology in this specific group; AASLD’s guidance is equally clear it carries risks, including a possible increase in hemorrhagic stroke and prostate cancer, and should only be used under a doctor’s supervision3. Bariatric surgery is another option AASLD’s guidance recognizes for people who meet standard surgery criteria, with resolution of steatohepatitis without worsening fibrosis in a large majority of patients a year after surgery3. None of these options remove the need for sound nutrition afterward. Because MASLD shares risk factors with heart disease, many of these food choices also support the goals in our guide to heart-healthy eating.
Supplements and “Liver Detox” Claims
It is worth saying plainly: no dietary supplement, tea, or cleanse is proven to “detox” the liver, and a healthy liver already does this job continuously on its own. The NIH’s LiverTox database, which tracks drug- and supplement-induced liver injury, documents that herbal and dietary supplements have caused harm ranging from mild enzyme elevations to acute liver failure requiring transplant, and notes many supplement products are complex mixtures with a history of contamination and mislabeled ingredients10. Products marketed for weight loss, bodybuilding, and “liver cleansing” are disproportionately represented among supplements linked to liver injury. This does not mean every supplement is dangerous, but more is not automatically safer for the liver, and any supplement should be reviewed with your doctor or dietitian. A marketing claim about cleansing or detoxing the liver is a reason for skepticism, not reassurance.
When to See a Hepatologist, and What Tests Are Used
Most people with MASLD are diagnosed and managed by a primary care doctor, and diet change is often enough on its own. A referral to a liver specialist becomes more important with signs of more advanced disease. NIDDK describes a stepwise approach: blood tests for liver enzymes, then noninvasive fibrosis scores such as FIB-4, calculated from routine labs and age; imaging such as ultrasound, CT, or MRI to confirm fat in the liver; and, when needed, elastography—including vibration-controlled transient elastography, shear wave elastography, or magnetic resonance elastography—to estimate liver stiffness as a marker of scarring. Liver biopsy remains the only test that can confirm a MASH diagnosis and grade severity, typically reserved for cases where noninvasive tests suggest more advanced disease6. AASLD’s clinical guidance for primary care describes FIB-4 as the recommended first step: scores below roughly 1.3 suggest a low likelihood of advanced fibrosis, while an indeterminate or higher score should prompt follow-up elastography and, depending on the result, referral to a hepatologist9. If your doctor has mentioned an elevated FIB-4 score, an abnormal elastography reading, or persistently elevated liver enzymes, that is a reasonable point to ask about a hepatology referral.
How a Dietitian Helps, and How to Find the Right One
A registered dietitian nutritionist translates all of the above into a plan that fits your kitchen, schedule, and preferences, rather than a generic handout. That typically includes setting a realistic, sustained weight-loss pace instead of a crash diet; building a Mediterranean-style pattern around foods you will keep eating; working through label reading for added sugar and fructose; coordinating protein and meal timing around exercise to protect muscle; and adjusting the plan as labs, weight, or medications change. For people managing MASLD alongside diabetes, high blood pressure, or high cholesterol, a dietitian can align the eating pattern across those conditions instead of following separate, conflicting advice for each.
When looking for a dietitian for fatty liver disease, look for someone experienced with metabolic and liver-related nutrition rather than a general wellness coach, since MASLD care benefits from familiarity with lab-based fibrosis risk, weight-loss pacing, and how nutrition needs shift if a GLP-1 medication or bariatric surgery becomes part of your care. You can search for a dietitian who specializes in liver and metabolic health directly, or browse the full directory of registered dietitian nutritionists to compare credentials and specialties near you.
Frequently Asked Questions
Can fatty liver disease actually be reversed with diet?
Simple fatty liver (steatosis) often improves and can normalize with sustained weight loss of about 3% to 5% and a change in eating pattern. More advanced disease, with inflammation or scarring, can also improve, but generally needs greater weight loss, more time, and sometimes medication, and existing scarring may not fully disappear even when the underlying disease is well controlled3.
What foods should I avoid with fatty liver?
Priority targets are sugar-sweetened drinks and foods high in added fructose, refined grains and pastries, fried and heavily processed foods, and excess alcohol—the items most consistently linked to liver fat and fibrosis progression in the evidence AASLD reviewed3.
Is intermittent fasting or keto better than Mediterranean eating for MASLD?
Neither has the depth or consistency of evidence that Mediterranean-style eating has for MASLD specifically. Some people lose weight successfully on these approaches, and weight loss itself helps regardless of method, but the liver benefits tied to lower fructose intake, olive oil, and fish are best documented within a Mediterranean pattern3.
Do I need to give up alcohol completely?
It depends on your stage of disease. NIDDK advises minimizing alcohol if you have NAFLD, and most hepatologists recommend avoiding it entirely once MASH, significant fibrosis, or cirrhosis is present5. This is a conversation to have directly with your own doctor, since individual risk varies.
Are liver detox supplements or cleanses worth trying?
No credible evidence supports supplement or tea “cleanses” for liver health, and some herbal and dietary supplements have been documented causes of liver injury10. Diet change, weight loss, and, when appropriate, prescribed medication are the approaches with actual evidence behind them.
How is MASLD different from just being overweight?
Body weight is one of several cardiometabolic risk factors used to diagnose MASLD, but the condition occurs across a range of body sizes, and not everyone with excess weight develops fatty liver. MASLD is diagnosed by finding fat in the liver plus at least one metabolic risk factor, such as high blood pressure, high triglycerides, or prediabetes, regardless of body mass index alone1.
References
- Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023. pmc.ncbi.nlm.nih.gov
- American Association for the Study of Liver Diseases. New MASLD Nomenclature. aasld.org
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023. pmc.ncbi.nlm.nih.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Definition & Facts of NAFLD & NASH. niddk.nih.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, & Nutrition for NAFLD & NASH. niddk.nih.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of NAFLD & NASH. niddk.nih.gov
- U.S. Food and Drug Administration. FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. March 2024. fda.gov
- U.S. Food and Drug Administration. Drugs@FDA approval history, Wegovy (semaglutide) NDA 215256, supplement approved August 15, 2025 for MASH with fibrosis. accessdata.fda.gov
- American Association for the Study of Liver Diseases. Spare Me the Jab: Noninvasive Assessment of Patients with MASLD. aasld.org
- National Institutes of Health. LiverTox: Herbal and Dietary Supplements. NCBI Bookshelf. ncbi.nlm.nih.gov